Luliconazole CAS 187164-19-8 Ubunyulu ≥99.0% HPLC Factory API High Quality
Ukubonelela ngeLuliconazole kunye nabaPhakathi abaNxulumeneyo
Luliconazole CAS 187164-19-8
(1-Imidazolyl)acetonitrile CAS 98873-55-3
(S) -2,4-Dichloro-α-(Chloromethyl)benzyl Utywala CAS 126534-31-4
Igama leMchiza | Luliconazole |
Izithethantonye | (2E)-2-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile;NND 502 |
Inombolo yeCAS | 187164-19-8 |
Inombolo yeCAT | RF-API110 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C14H9Cl2N3S2 |
Ubunzima beMolekyuli | 354.27 |
Indawo yokunyibilika | 150.0 ukuba 154.0℃ |
Ujikelezo oluKhethekileyo [a]20/D | -48.0 ° ukuya -53.0 ° (C=1, DMF) |
Ukunyibilika | Ukunganyibiliki emanzini;Inyibilika kwi-acetone;Inyibilika kancinane kwiMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Okumhlophe-kuMhlophe ukuya kuMthubi wePowder oyiCrystalline oKhanyayo |
Ukuchongwa kwe-IR | I-spectrum ye-infrared yesampuli kufuneka ihambelane naleyo yomgangatho wereferensi |
Ukuchongwa kwe-HPLC | Ixesha lokugcinwa kwencopho enkulu yesisombululo sesampulu kufuneka ihambelane nesisombululo esisemgangathweni njengoko sifunyenwe kuvavanyo |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.20% |
Iintsimbi ezinzima (Pb) | ≤20ppm |
Izinto ezinxulumeneyo | |
Nakuphi na Ukungacoceki komntu | ≤0.20% |
Ukungcola ngokupheleleyo | ≤0.50% |
Izinyibilikisi ezishiyekileyo | |
IMethanol | ≤3000ppm |
Acetonitrile | ≤410ppm |
Dichloromethane | ≤600ppm |
N-Hexane | ≤290ppm |
I-Ethyl Acetate | ≤5000ppm |
Tetrahydrofuran | ≤720ppm |
I-Methyl tert-Butyl Ether | ≤5000ppm |
N-Heptane | ≤5000ppm |
I-Triethylamine | ≤320ppm |
I-Dimethyl Sulfoxide | ≤5000ppm |
Ubunyulu / Indlela yokuHlalutya | ≥99.0% (HPLC) (kwisiseko esomileyo) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-Luliconazole (i-CAS: 187164-19-8) yintsholongwane ye-antifungal imidazole ene-spectrum ebanzi kunye nomsebenzi onamandla we-antifungal.I-Luliconazole luhlobo lwe-analogue ye-lanoconazole.Inokuphazamisa ukudityaniswa kodonga lweseli lomngundo kunye nokukhula komngundo ngokuncipha kwamanqanaba eergosterol ngokuthintela umsebenzi we-lanosterol demethylase.Ngaphandle kokuba isetyenziselwa unyango lonyawo lomdlali, i-jock itch kunye ne-ringworm, iye yaphuhliswa kunyango lwe-onychomycosis (i-nail fungus) kwaye ngoku sele ingene kwisigaba sezonyango III.Le mveliso yaphuhliswa ekuqaleni yi-Japan pesticide Corporation (NihonNohyaku Co., Ltd.).NgoNovemba ka-2013, i-FDA iphumeze i-1% ye-luliconazole cream yokungena kwimarike yonyango lwe-topical yonyawo lomdlali we-interdigital, i-jock itch kunye ne-ringworm enegama lezorhwebo elithi Luzu kwaye yaqala ukungena kwimarike eMntla Melika.Kwangoko ngo-Epreli ka-2005, i-luliconazole yayivunyiwe ukuba ingene kwimarike eJapan phantsi kwegama lorhwebo elithi Lulicon.NgoJanuwari 2010 kunye noJuni 2012, yavunywa ukuba ithengiswe eIndiya naseTshayina, ngokulandelanayo.